Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
   PubMed Web of Science ®Google Scholar
• Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science. 2011;331:1553–1558.
   PubMed Web of Science ®Google Scholar
• Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318:1108–1113.
   PubMed Web of Science ®Google Scholar
• Greenman C, Stephens P, Smith R, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446:153–158.
   PubMed Web of Science ®Google Scholar
• Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett. 2008;266:99–115.
   PubMed Web of Science ®Google Scholar
• Zhang L, Kim S, Jia G, et al. Exome sequencing of normal and isogenic transformed human colonic epithelial cells (HCECs) reveals novel genes potentially involved in the early stages of colorectal tumorigenesis. BMC Genomics. 2015;16:S8.
   PubMed Web of Science ®Google Scholar
• Richards NG, Schuster SM. Mechanistic issues in asparagine synthetase catalysis. Adv Enzymol Relat Areas Mol Biol. 1998;72:145–198.
   PubMedGoogle Scholar
• Milman HA, Cooney DA. The distribution of L-asparagine synthetase in the principal organs of several mammalian and avian species. Biochem J. 1974;142:27–35.
   PubMed Web of Science ®Google Scholar
• Milman HA, Cooney DA, Young DM. Role of pancreatic L-asparagine synthetase in homeostasis of L-asparagine. Am J Physiol. 1979;236:E746–E753.
   PubMed Web of Science ®Google Scholar
• Tezuka K, Nakayama H, Honda K, et al. Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation. Int J Hematol. 2002;75:201–206.
   PubMed Web of Science ®Google Scholar
• Balasubramanian MN, Butterworth EA, Kilberg MS. Asparagine synthetase: regulation by cell stress and involvement in tumor biology. Am J Physiol Endocrinol Metab. 2013;304:E789–E799.
   PubMed Web of Science ®Google Scholar
• Li H, Zhou F, Du W, et al. Knockdown of asparagine synthetase by RNAi suppresses cell growth in human melanoma cells and epidermoid carcinoma cells. Biotechnol Appl Biochem. 2015. [Epub ahead of print]. doi: 10.1002/bab.1383.
   Web of Science ®Google Scholar
• Yang H, He X, Zheng Y, et al. Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer. Chem Biol Drug Des. 2014;84:578–584.
   PubMed Web of Science ®Google Scholar
• Liu RY, Dong Z, Liu J, et al. Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells. Mol Cancer Ther. 2013;12:2157–2166.
   PubMed Web of Science ®Google Scholar
• Sircar K, Huang H, Hu L, et al. Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer. Am J Pathol. 2012;180:895–903.
   PubMed Web of Science ®Google Scholar
• Zhang B, Dong LW, Tan YX, et al. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma. Br J Cancer. 2013;109:14–23.
   PubMed Web of Science ®Google Scholar
• Panosyan EH, Wang Y, Xia P, et al. Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors. Mol Cancer Res. 2014;12:694–702.
   PubMed Web of Science ®Google Scholar
• Kucuk C, Hu X, Jiang B, et al. Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Clin Cancer Res. 2015;21:1699–1711.
   PubMed Web of Science ®Google Scholar
• Scian MJ, Stagliano KE, Deb D, et al. Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes. Oncogene. 2004;23:4430–4443.
   PubMed Web of Science ®Google Scholar
• Cui H, Darmanin S, Natsuisaka M, et al. Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin. Cancer Res. 2007;67:3345–3355.
   PubMed Web of Science ®Google Scholar
• Fafournoux P, Bruhat A, Jousse C. Amino acid regulation of gene expression. Biochem J. 2000;351:1–12.
   PubMed Web of Science ®Google Scholar
• Prager MD, Bachynsky N. Asparagine synthetase in asparaginase resistant and susceptible mouse lymphomas. Biochem Biophys Res Commun. 1968;31:43–47.
   PubMed Web of Science ®Google Scholar
• Hutson RG, Kitoh T, Moraga Amador DA, et al. Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. Am J Physiol. 1997;272:C1691–C1699.
   PubMed Web of Science ®Google Scholar
• Amylon MD, Shuster J, Pullen J, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a pediatric oncology group study. Leukemia. 1999;13:335–342.
   PubMed Web of Science ®Google Scholar
• Aslanian AM, Fletcher BS, Kilberg MS. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. Biochem J. 2001;357:321–328.
   PubMed Web of Science ®Google Scholar
• Pui CH, Relling MV, Campana D, et al. Childhood acute lymphoblastic leukemia. Rev Clin Exp Hematol. 2002;6:161–180. discussion 200–202.
   PubMedGoogle Scholar
• Zwaan CM, Kaspers GJ, Pieters R, et al. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood. 2002;99:245–251.
   PubMed Web of Science ®Google Scholar
• Apostolidou E, Swords R, Alvarado Y, et al. Treatment of acute lymphoblastic leukaemia : a new era. Drugs. 2007;67:2153–2171.
   PubMed Web of Science ®Google Scholar
• Lorenzi PL, Reinhold WC, Rudelius M, et al. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Mol Cancer Ther. 2006;5:2613–2623.
   PubMed Web of Science ®Google Scholar
• Smallwood TL, Small GW, Suter SE, et al. Expression of asparagine synthetase predicts in vitro response to L-asparaginase in canine lymphoid cell lines. Leuk Lymphoma. 2014;55:1357–1365.
   PubMed Web of Science ®Google Scholar
• Lin CY, Sheu MJ, Li CF, et al. Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance. Tumour Biol. 2014;35:6823–6830.
   PubMed Web of Science ®Google Scholar
• Hettmer S, Schinzel AC, Tchessalova D, et al. Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma. eLife. 2015;4:e09436.
   PubMed Web of Science ®Google Scholar